Salgia, R. ., Kulkarni, P. ., & Gill, P. . (2018). EphB4: A promising target for upper Aerodigestive malignancies. Biochimica Et Biophysica Acta. https://doi.org/10.1016/j.bbcan.2018.01.003 (Original work published 2018)

Jeankumar, V. ., Saxena, S. ., Vats, R. ., Reshma, R. ., Janupally, R. ., Kulkarni, P. ., … Sriram, D. . (2016). Structure-Guided Discovery of Antitubercular Agents That Target the Gyrase ATPase Domain. ChemMedChem, 11(5), 539-48. https://doi.org/10.1002/cmdc.201500556 (Original work published 2016)

Medapi, B. ., Renuka, J. ., Saxena, S. ., Sridevi, J. ., Medishetti, R. ., Kulkarni, P. ., … Sriram, D. . (2015). Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors. Bioorganic & Medicinal Chemistry, 23(9), 2062-78. https://doi.org/10.1016/j.bmc.2015.03.004 (Original work published 2015)

Jeankumar, V. ., Reshma, R. ., Janupally, R. ., Saxena, S. ., Sridevi, J. ., Medapi, B. ., … Sriram, D. . (2015). Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. Organic & Biomolecular Chemistry, 13(8), 2423-31. https://doi.org/10.1039/c4ob02049a (Original work published 2015)

Jeankumar, V. ., Renuka, J. ., Kotagiri, S. ., Saxena, S. ., Kakan, S. ., Sridevi, J. ., … Sriram, D. . (2014). Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues. ChemMedChem, 9(8), 1850-9. https://doi.org/10.1002/cmdc.201402035